Anna Almonte, MD, DO
Obstetrics & Gynecology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Almonte’s office at (916) 920-2082 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$936
Medicare paid this office $936 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 67 · Women 100% · Health risk score 1.36. Sicker patients than 9 in 10 peers; the typical obstetrics & gynecology clinician is at 0.88.
The office billed $2,435, Medicare allowed $1,287 and paid $936; for 19 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$16,850 in 2024
Medicaid paid $16,850 for 2,773 billed services this clinician did in 2024, up to 165 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 42 | $6,809 |
| Prenatal care, at-risk enhanced service; antepartum management | 993 | $6,432 |
| Prenatal care, at-risk assessment | 63 | $902 |
| Short return visit (20+ min) | 158 | $777 |
| Postpartum care only (separate procedure) | 131 | $439 |
| URINE PREGNANCY TEST | 521 | $429 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 522 | $376 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 12 | $247 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 289 | $218 |
| Service | 15 | $114 |
| Service | 14 | $107 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $0 |
| 2024 | 2,773 | 12 | 165 | $16,850 |
| 2023 | 347 | 6 | 47 | $1,333 |
| 2020 | 1,308 | 8 | 107 | $101,235 |
| 2019 | 1,189 | 9 | 85 | $135,621 |
| 2018 | 12 | 1 | 12 | $642 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 50 | $542 |
| Prenatal care, at-risk enhanced service; antepartum management | 46 | $411 |
| New patient visit (30+ min) | 16 | $177 |
| URINE PREGNANCY TEST | 163 | $176 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 58 | $28 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 14 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 496 | $101,186 |
| Short return visit (20+ min) | 274 | $27 |
| Short return visit | 258 | $22 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 18 | $0 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 40 | $0 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years | 19 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 33 | $0 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 170 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 667 | $135,615 |
| Short return visit | 185 | $6 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 15 | $0 |
| Short return visit (20+ min) | 120 | $0 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 59 | $0 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years | 20 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 53 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 32 | $0 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 38 | $0 |
2018
| Cesarean delivery | 12 | $642 |
Drugs they prescribed that Part D paid
$2,917
Pharmacies billed $2,917 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 37) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
32 generic and fewer than 11 brand-name prescriptions · $2,917 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 37 | 13 | 0% (0) | None | $2,917 |
| 2023 | 14 | None | 0% (0) | None | $1,767 |
| 2020 | 32 | 13 | 0% (0) | None | $816 |
| 2019 | 27 | 11 | None | None | $1,389 |
| 2015 | 22 | None | None | None | $1,410 |
| 2013 | 15 | None | None | None | $354 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$50 in 2025
| 2025 | 2 | 2 | None | $50 |
| 2024 | 2 | 2 | None | $42 |
| 2023 | 6 | 10 | None | $180 |
| 2019 | 1 | 3 | None | $35 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $29 | 1 payment
|
| Abbvie | Qulipta | $21 | 1 payment
|
See all 2 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-26 | Caplyta | $29 |
| Abbvie | Meals · 2025-11-25 | Qulipta | $21 |
See earlier years (2024, 2023, 2019)
2024: $42
| GlaxoSmithKline | Bexsero | $27 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Mirena | $15 | 1 payment
|
2023: $180
| GlaxoSmithKline | Bexsero | $55 | 2 payments
|
| Organon | Nexplanon | $41 | 3 payments
|
| Agile Therapeutics | Twirla | $31 | 2 payments
|
| Sumitomo Pharma America | Myfembree | $23 | 1 payment
|
| Evofem Biosciences | Phexxi | $17 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Mirena | $14 | 1 payment
|
2019: $35
| GlaxoSmithKline | Bexsero | $35 | 3 payments
|
Professional record
- NPI
- 1104970946
- Licence
- CA 20A8160, CA 20A9160, CA 29A9160
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207V00000X (207V00000X); Federal specialty code 207RG0300X (207RG0300X)
- Mailing address
- Po Box 981181, West Sacramento, CA, 95798
- NPI first listed
- 2007-01-22
- NPI last updated
- 2023-10-18
- NPI record certified
- 2023-10-18
This is when the NPI record was last certified, not a medical board exam.